I
Imsight Medical
Develops artificial intelligence assisted medical imaging analysis tools
About Imsight Medical
Imsight Medical Technology, established in 2017, operates as a developer of artificial intelligence-based medical imaging analysis tools. The company was incubated at the Medical Image Analysis laboratory at The Chinese University of Hong Kong (CUHK) and founded by a group of professors and PhDs from the university. The founder, Chen Hao, was featured in the journal Nature in December 2020 to discuss the future of AI in medicine. The company's CEO for the Shenzhen Division is Zhang Hongwei, who brings 20 years of experience in the medical device industry. Since its inception, Imsight has secured multiple rounds of financing, including a Series B round in April 2020 led by Lenovo Capital and Incubator Group and China Merchants.
The firm's business model is centered on providing AI-powered software solutions to healthcare providers, primarily hospitals and diagnostic centers, on a B2B basis. Its technology is designed to integrate with existing clinical workflows, receiving imaging scans from various modalities for automated analysis. This addresses the challenges of increasing workloads, long reporting times, and diagnostic inconsistencies faced by radiologists and pathologists. The company's AI platform analyzes a vast database of medical scans to help clinicians identify diseases more efficiently. By automating the quantification of lesions and other visual signs, the software significantly reduces the time required for diagnosis and reporting.
Imsight's product portfolio includes several specialized tools for different diagnostic purposes. Lung-Sight provides automated lung nodule detection and analysis from CT images, generating reports within seconds. Another product, Cervical-Sight, is an AI screening system for cervical cancer that analyzes digitalized slide images from Pap smear tests to identify abnormal cells and classify them according to TBS guidelines. The system can process over 2,000 slides daily, serving as a second reader to alleviate the workload of physicians. The company also offers DR-Sight and Rib-Sight, among others, and provides co-creation opportunities to tailor solutions for specific client needs. These products are deployed in over 30 hospitals and screening centers, mainly in Hong Kong and the Greater Bay Area.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 6
- Open positions
- None listed
- Dealroom signal
- 46.6/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Diagnostics, Hard Tech, DT and LS, science-based
- Technology
- Artificial Intelligence, Deep Tech, Machine Learning, Computer Vision
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jun 2018 | $15M | $61M | China Merchants Capital | — |
| SERIES A✓Equity / VC | Mar 2018 | $9.5M | $38M | Shenzhen Capital Group | — |
Growth signals
Latest recorded traffic for Imsight Medical is 100 monthly website visits, down 44.4% over the last three months. Imsight Medical's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Imsight Medical in the Sha Tin District ecosystem
The Imsight Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Lenovo Capital and Incubator Group (LCIG)
Shenzhen Capital Group- CCChina Merchants Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Imsight Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Imsight Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









